Kidney and cardiovascular outcomes SURPASS-4 kidney composite HR 0.58, slower eGFR decline (-1.4 vs -3.6 mL/min/1.73m2/yr), UACR -6.8% vs +36.9%
BPC-157 promotes angiogenesis, which raises questions about use in individuals with active cancers where blood vessel growth could support tumor progression
Every batch of BPC-157 (10mg) + TB-500 (10mg) Bundle is tested for purity and identity using industry-standard methods
3 Extended Administration Pharmacokinetics in DIO Mice Neelakantan et al., Biochemical Pharmacology (2024) This study reported a 28-day once-daily administration protocol of 5-Amino-1MQ in diet-induced obese mice, characterizing plasma pharmacokinetics, tissue distribution, and effects on body composition, fatty liver pathology, and circulating biomarkers
Disclaimer: This content is for informational purposes only and does not constitute medical advice